trial · primary record
Rizatriptan 10 mg + Naproxen 550mg
Migraine
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 2068 |
| Primary completion | 2024-11-30 |
| Primary endpoint | 2-hour pain-free |
| Registry ID | NCT04384367 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:13.393Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04384367
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.